AVROBIO Receives Orphan-Drug Designation from the FDA for AVR‑RD‑02 for the Treatment of Gaucher Disease Read more
Exclusive speaker interview with OnDigital Health Consulting released for Disruptive Technologies in Pharma 2020 Read more
Pliant Therapeutics Announces Strategic Collaboration to Develop Novel Therapies for NASH and Fibrotic Diseases Read more
Janssen Seeks to Expand Use of TREMFYA (guselkumab) in the Treatment of Adults With Active Psoriatic Arthritis Read more
Exclusive Interview with Cedric Gysel Johnson and Johnson’s Cedric Gysel for Pre-Filled Syringe and Injectable Drug Devices 2020 Read more
Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharma Following Positive Phase 2a Proof-of-Concept Study Read more